OCULAR THERAPEUTIX, INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Dugel Pravin | See Remarks | Sale | 19,530 | $12.04 | $235,141 | 3,157,960 | Nov 26, 2025 |
| Nayak Sanjay | Chief Strategy Officer | Sale | 1,878 | $12.04 | $22,611 | 277,860 | Nov 24, 2025 |
| Kaiser Peter | Chief Development Officer | Sale | 3,007 | $12.02 | $36,144 | 191,433 | Nov 24, 2025 |
| Heier Jeffrey S. | Chief Scientific Officer | Sale | 3,469 | $12.04 | $41,767 | 245,940 | Nov 24, 2025 |
| Saroj Namrata | Chief Business Officer | Sale | 25,865 | $10.74 | $277,790 | 174,135 | Nov 5, 2025 |
| Anderman Todd | Chief Legal Officer | Sale | 11,132 | $12.34 | $137,369 | 87,568 | Oct 8, 2025 |
| Kaiser Peter | Chief Development Officer | Sale | 9,653 | $11.03 | $106,473 | 194,440 | Oct 2, 2025 |
| Heier Jeffrey S. | Chief Scientific Officer | Sale | 10,502 | $11.04 | $115,942 | 249,409 | Oct 2, 2025 |
| Dugel Pravin | See Remarks | Gift | 49,754 | — | — | 49,754 | Sep 9, 2025 |
| Notman Donald | See Remarks | Sale | 1,066 | $12.43 | $13,250 | 308,807 | Sep 2, 2025 |
| Kaiser Peter | Chief Development Officer | Sale | 3,011 | $12.04 | $36,252 | 204,093 | Aug 25, 2025 |
| Nayak Sanjay | Chief Strategy Officer | Sale | 1,885 | $12.04 | $22,695 | 279,738 | Aug 25, 2025 |
| Heier Jeffrey S. | Chief Scientific Officer | Sale | 3,063 | $12.04 | $36,879 | 259,911 | Aug 25, 2025 |
| Dugel Pravin | See Remarks | Sale | 21,494 | $12.04 | $258,788 | 3,227,244 | Aug 25, 2025 |
| Waheed Nadia | Chief Medical Officer | Award / Grant | 40,363 | — | — | 247,168 | Aug 12, 2025 |
| Dugel Pravin | See Remarks | Gift | 200,332 | — | — | 3,298,767 | Jun 12, 2025 |
| Hong Seung Suh | — | Award / Grant | 14,000 | — | — | 46,933 | Jun 11, 2025 |
| RAINES MERILEE | — | Award / Grant | 14,000 | — | — | 46,933 | Jun 11, 2025 |
| LINDSTROM RICHARD L MD | — | Award / Grant | 14,000 | — | — | 143,145 | Jun 11, 2025 |
| Williams Leslie J. | — | Award / Grant | 14,000 | — | — | 51,433 | Jun 11, 2025 |
| Warden Charles M | — | Award / Grant | 14,000 | — | — | 86,464 | Jun 11, 2025 |
| Graves Adrienne L | — | Award / Grant | 14,000 | — | — | 50,000 | Jun 11, 2025 |
| Waheed Nadia | Chief Medical Officer | Sale | 13,861 | $8.05 | $111,581 | 206,805 | Jun 2, 2025 |
| Nayak Sanjay | Chief Strategy Officer | Sale | 1,862 | $7.17 | $13,351 | 281,623 | May 23, 2025 |
| Kaiser Peter | Chief Development Officer | Sale | 2,974 | $7.17 | $21,324 | 207,104 | May 23, 2025 |
| Heier Jeffrey S. | Chief Scientific Officer | Sale | 3,024 | $7.18 | $21,712 | 262,974 | May 23, 2025 |
| Dugel Pravin | See Remarks | Sale | 21,219 | $7.18 | $152,352 | 3,499,099 | May 23, 2025 |
| LINDSTROM RICHARD L MD | — | Purchase | 10,000 | $6.96 | $69,600 | 172,704 | May 8, 2025 |
| Dugel Pravin | See Remarks | Sale | 21,475 | $6.87 | $147,533 | 3,520,318 | Feb 24, 2025 |
| Heier Jeffrey S. | Chief Scientific Officer | Sale | 3,061 | $6.87 | $21,029 | 265,998 | Feb 24, 2025 |
| Kaiser Peter | Chief Development Officer | Sale | 3,009 | $6.87 | $20,672 | 210,078 | Feb 24, 2025 |
| Nayak Sanjay | Chief Strategy Officer | Sale | 1,895 | $6.84 | $12,962 | 283,485 | Feb 24, 2025 |
| Dugel Pravin | See Remarks | Award / Grant | 1,250,000 | — | — | 2,041,793 | Feb 11, 2025 |
| Waheed Nadia | Chief Medical Officer | Award / Grant | 79,000 | — | — | 220,666 | Feb 11, 2025 |
| Notman Donald | See Remarks | Award / Grant | 115,000 | — | — | 308,444 | Feb 11, 2025 |
| Nayak Sanjay | Chief Strategy Officer | Award / Grant | 111,000 | — | — | 285,380 | Feb 11, 2025 |
| Notman Donald | See Remarks | Sale | 6,301 | $7.84 | $49,400 | 204,563 | Feb 4, 2025 |
| Heier Jeffrey S. | Chief Scientific Officer | Sale | 2,948 | $9.01 | $26,561 | 269,059 | Nov 25, 2024 |
| Kaiser Peter | Chief Development Officer | Sale | 2,897 | $9.01 | $26,102 | 213,087 | Nov 25, 2024 |
| Nayak Sanjay | Chief Strategy Officer | Sale | 1,814 | $9.00 | $16,326 | 174,380 | Nov 25, 2024 |
| Dugel Pravin | See Remarks | Sale | 20,680 | $9.01 | $186,327 | 791,793 | Nov 25, 2024 |
| Anderman Todd | Chief Legal Officer | Award / Grant | 98,700 | — | — | 98,700 | Oct 7, 2024 |
| Kaiser Peter | Chief Development Officer | Award / Grant | 100,000 | — | — | 215,984 | Oct 2, 2024 |
| Heier Jeffrey S. | Chief Scientific Officer | Award / Grant | 100,000 | — | — | 272,007 | Oct 2, 2024 |
| Notman Donald | See Remarks | Award / Grant | 11,034 | — | — | 208,988 | Aug 29, 2024 |
| Nayak Sanjay | Chief Strategy Officer | Sale | 1,832 | $9.02 | $16,525 | 176,194 | Aug 23, 2024 |
| Dugel Pravin | See Remarks | Sale | 20,880 | $9.02 | $188,338 | 812,473 | Aug 23, 2024 |
| Hong Seung Suh | — | Award / Grant | 12,000 | — | — | 32,933 | Jul 24, 2024 |
| RAINES MERILEE | — | Award / Grant | 12,000 | — | — | 32,933 | Jul 24, 2024 |
| Williams Leslie J. | — | Award / Grant | 12,000 | — | — | 37,433 | Jul 24, 2024 |